IP Library Granted Patent US 10,220,066
Granted Patent B2
US 10,220,066 · App. 16/015,711 · Granted Mar 5, 2019

Treatment of virus-based diseases of the skin

Inventor: Erika N. Angle (Bedford, MA)
Assignee: IXCELA, INC.
A61K36/288A61K9/0014A61K31/4196A61K31/7076
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,220,066
App. No.
16/015,711
Granted
Mar 5, 2019
Kind
B2
Abstract

A method for treatment of virus-based diseases of the skin, in particular, herpes simplex virus type-1 and herpes zoster, which comprises topically administering to the skin of a subject suffering from a virus-based disease of the skin a therapeutically amount of an aqueous, aqueous/alcohol, or natural plant oil extract of dandelion.

Claims (6)

1. A method for treating herpes zoster in a human in need thereof consisting essentially of topically administering to the skin of the human in need thereof a therapeutically effective amount of an aqueous or aqueous/alcohol extract of Mongolian dandelion and an oil selected from the group consisting of flax oil, almond oil, coconut oil, jojoba oil, lemon oil, olive oil, sesame seed oil, and sunflower oil.

2. A method for treating herpes zoster in a human in need thereof consisting essentially of topically administering to the skin of the human in need thereof a therapeutically effective amount of an aqueous or aqueous/alcohol extract of Mongolian dandelion, an oil selected from the group consisting of flax oil, almond oil, coconut oil, jojoba oil, lemon oil, olive oil, sesame seed oil, and sunflower oil, and a water or alcohol carrier, in a concentration of between 1:1 and 1:10 extract of dandelion to the water or alcohol carrier.

3. The method of claim 2 , wherein the extract of dandelion is administered diluted in a water or alcohol carrier in a concentration of 1:1 extract of dandelion to water or alcohol.

4. The method of claim 2 , wherein the extract of dandelion is administered diluted in a water or alcohol carrier in a concentration of 1:2 extract of dandelion to water or alcohol.

5. The method of claim 2 , wherein the extract of dandelion is administered diluted in a water or alcohol carrier in a concentration of 1:5 extract of dandelion to water or alcohol.

6. The method of claim 2 , wherein the extract of dandelion is administered diluted in a water or alcohol carrier in a concentration of 1:10 extract of dandelion to water or alcohol.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2022
From: ANGLE, ERIKA N.
To: COUNTERPOINT HEALTH SOLUTIONS, INC.
Reel/Frame 061809/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2022
From: IXCELA, INC.
To: ANGLE, ERIKA
Reel/Frame 061809/0438 →
CHANGE OF NAME Recorded Nov 17, 2022
From: COUNTERPOINT HEALTH SOLUTIONS, INC.
To: IXCELA, INC.
Reel/Frame 061959/0386 →
Continuity (3)
Division 14737164 · Jun 11, 2015
Provisional Application 62010860 · Jun 11, 2014
Related Publication 20180296620A1 · Oct 18, 2018
Cited By (1)
US 12,485,153